Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach
Favipiravir is a selective RNA polymerase inhibitor and a broad-spectrum antiviral drug, an
important agent used in viral infections, including Ebola, Lassa, and COVID-19. This study …
important agent used in viral infections, including Ebola, Lassa, and COVID-19. This study …
Pulmonary delivery of favipiravir in rats reaches high local concentrations without causing oxidative lung injury or systemic side effects
O Akbal-Dagistan, M Sevim, LS Sen, NS Basarir… - Pharmaceutics, 2022 - mdpi.com
Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic
safety; however, its oral administration was associated with systemic side effects in …
safety; however, its oral administration was associated with systemic side effects in …
Assessment of toxicological effects of favipiravir (T‐705) on the lung tissue of rats: An experimental study
This study aimed to present new data on the side effects of favipiravir on healthy lung tissue
and the respiratory system. In the study, two different durations (5 and 10 days) were …
and the respiratory system. In the study, two different durations (5 and 10 days) were …
Evaluation of the use of Favipiravir on the Hematology value of COVID-19 patients at Anna Bekasi Hospital in 2021
F Setiadi, W Widyastuti - PHARMACY: Jurnal Farmasi …, 2023 - jurnalnasional.ump.ac.id
The COVID-19 pandemic caused by the SARS-CoV-2 virus occurred in Indonesia in early
2020. Favipiravir was used as an antiviral for the disease due to an emergency. The results …
2020. Favipiravir was used as an antiviral for the disease due to an emergency. The results …
Experimental Studies on Some Drugs Used in Covid-19 Treatment (Favipiravir and Dexamethasone) in Albino Rats
MS Abou El-Fetouh, NM El-Seddawy… - Journal of Advanced …, 2023 - advetresearch.com
In this study, the side effects of some anti-covid-19 drugs (Favipiravir and Dexamethasone)
were evaluated through the pathological, and clinicopathological changes in the tissues of …
were evaluated through the pathological, and clinicopathological changes in the tissues of …
Effect of favipiravir use on INR, PT, aPTT tests of COVID-19 patients
The 2019 coronavirus disease (COVID-19) has caused millions of cases worldwide. As the
pandemic progresses, understanding the effects of this disease remains important. We …
pandemic progresses, understanding the effects of this disease remains important. We …
[PDF][PDF] Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach
A Ulucan, FM Kandemir - researchgate.net
Favipiravir is a selective RNA polymerase inhibitor and a broad-spectrum antiviral drug, an
important agent used in viral infections, including Ebola, Lassa, and COVID-19. This study …
important agent used in viral infections, including Ebola, Lassa, and COVID-19. This study …